Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

Stojaković et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69dabaea4a1e15904c835e83 — DOI: https://doi.org/10.1002/hep.21741

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases· 1999 · 152 citations
2. Endoscopic ultrasound in the evaluation of Barrett's esophagus: a preliminary report.· 1995 · 17 citations
3. Experience With Statin Use in Patients With Chronic Hepatitis C Infection· 2005 · 28 citations
4. Statin Induction of Liver Fatty Acid-Binding Protein (L-FABP) Gene Expression Is Peroxisome Proliferator-activated Receptor-α-dependent· 2004 · 94 citations
5. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.· 1998 · 1,566 citations